Niagen Bioscience, Inc. (NAGE)
5.02
+0.16
(+3.29%)
USD |
NASDAQ |
Feb 23, 16:00
5.15
+0.13
(+2.59%)
After-Hours: 04:16
Niagen Bioscience Total Liabilities (Quarterly) : 27.46M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 191.70M |
| Nephros, Inc. | 3.241M |
| Harrow, Inc. | 316.41M |
| Astrana Health, Inc. | 1.682B |
| Clover Health Investments Corp. | 218.73M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.14M |
| Shareholders Equity (Quarterly) | 70.68M |
| Debt to Equity Ratio | 0.0432 |
| Current Ratio | 4.122 |
| Net Debt Paydown Yield | 0.00% |